Related Experiment Video
Updated: Jul 6, 2026
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Comparison of two immortalized human cell lines to study nuclear receptor-mediated CYP3A4 induction
S Harmsen1, A S Koster, J H Beijnen
1Division of Biomedical Analysis, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands. s.harmsen@uu.nl
Abstract:
Since CYP3A4 is responsible for the biotransformation of over 50% of all clinically used drugs, induction results in an increased clearance of many concomitantly administered drugs, thereby decreasing treatment efficacy or, in the case of prodrugs, lead to severe intoxications. CYP3A4 induction is regulated by the pregnane X receptor, constitutive androstane receptor, and vitamin D receptor. Since these nuclear receptors show large interspecies differences, accurate prediction of nuclear receptor-mediated CYP3A4 induction in humans requires the use of human systems. Because primary cultures of human hepatocytes or enterocytes have major drawbacks like poor availability and poor reproducibility, human cell lines are a good alternative. In this study, the widely used HepG2 cell line was compared with the LS180 cell line to serve as a model to study CYP3A4 induction. There was a clear difference between the cell lines with respect to CYP3A enzyme expression and induction. In LS180, CYP3A4 was expressed and was found to be induced by prototypical nuclear receptor agonists, whereas in HepG2, CYP3A4 was nonresponsive to treatment with rifampicin, CITCO [6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-3,4-dichlorobenzyl) oxime], or calcitriol. We subsequently evaluated whether these host-cell differences also have an effect on CYP3A4 reporter gene activity. We clearly show that there are differences in CYP3A4 reporter activity between the cell lines, and based on these results and those found on mRNA and protein level, we conclude that LS180 is a more suitable cell line to study CYP3A4 induction than the widely used HepG2.
Insights
LS180 cells are a better model for studying CYP3A4 induction than HepG2 cells. LS180 cells express and respond to CYP3A4 induction, unlike HepG2 cells, which are unresponsive.
Area of Science:
- Pharmacology
- Drug Metabolism
- Cell Biology
Background:
- Cytochrome P450 3A4 (CYP3A4) metabolizes over 50% of clinical drugs.
- CYP3A4 induction affects drug efficacy and can cause toxicity.
- Nuclear receptors like PXR, CAR, and VDR regulate CYP3A4, but show interspecies differences.
Purpose of the Study:
- To compare HepG2 and LS180 cell lines as models for studying CYP3A4 induction.
- To evaluate the suitability of human cell lines for predicting nuclear receptor-mediated CYP3A4 induction.
Main Methods:
- Comparison of CYP3A4 expression and induction in HepG2 and LS180 cell lines.
- Treatment with prototypical nuclear receptor agonists (rifampicin, CITCO, calcitriol).
- Evaluation of CYP3A4 reporter gene activity, mRNA, and protein levels.
Main Results:
- LS180 cells expressed CYP3A4 and showed induction by agonists.
- HepG2 cells were nonresponsive to rifampicin, CITCO, and calcitriol.
- Significant differences in CYP3A4 reporter gene activity were observed between the cell lines.
Conclusions:
- LS180 cells are a more suitable model for studying CYP3A4 induction compared to HepG2 cells.
- Cell line choice is critical for accurate prediction of drug-induced CYP3A4 modulation.
